Federal grants to Vasarya Therapeutics, Inc.
Vasarya Therapeutics, Inc. in Camden Wyoming, Delaware received $1.8 million in federal grants from fiscal 2021 to 2025, across 2 awards. Its largest program was Cardiovascular Diseases Research, with $1.5 million. In fiscal 2025 it was awarded $1.1 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$1.8 million
- Awards2
- Awarded in FY 2025$1.1 million
- Largest award$1.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 0 | $0 |
| FY 2023 | 0 | $0 |
| FY 2024 | 2 | $652,171 |
| FY 2025 | 1 | $1.1 million |
Programs that fund Vasarya Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 1 | $1.5 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $295,921 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 2 | $1.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Translating a novel therapeutic approach to the treatment for idiopathic pulmonary fibrosis - project abstract the goal of this fast-track sbir application is to develop a novel drug candidate to treat idiopathic pulmonary fibrosis (IPF). Ipf is a fatal disease that remains uncurable and carries a m | Cardiovascular Diseases Research | September 15, 2024 | $1.5 million |
| Targeting a disease-specific conformation of fibronectin as a novel approach for liver fibrosis treatment - project abstract the overarching goal of this phase i sttr application is to evaluate the in vivo efficacy of a novel approach to hepatic fibrosis treatment and to explore its clinical transla | Diabetes, Digestive, and Kidney Diseases Extramural Research | May 28, 2024 | $295,921 |
Questions people ask
How much federal grant money does Vasarya Therapeutics, Inc. get?
$1.8 million in 2 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Vasarya Therapeutics, Inc. the most?
The Department of Health and Human Services, with $1.8 million in 2 awards.
What is Vasarya Therapeutics, Inc.'s largest federal grant?
$1.5 million under Cardiovascular Diseases Research, with its first action in the period on September 15, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Vasarya Therapeutics, Inc.?
Its largest are Cardiovascular Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Largest federal grant recipients in Delaware · Federal grants in Delaware